The VCCC Alliance is a powerful partnership between 10 leading research, academic and clinical institutions working together to expedite and amplify leading-edge cancer research, knowledge and expertise to improve outcomes for people affected by cancer.
Through innovation and collaboration, our alliance is leading integrated, research-driven, consumer-informed cancer research, education and patient care. By capitalising on our collective strengths, we are fundamentally changing the way we tackle cancer and accelerating the translation of scientific evidence into patient benefit.
The new VCCC Alliance Strategic Program Plan 2021-24 is a roadmap of integrated, innovative and ambitious programs designed to tackle the complexities and inequities of cancer outcomes in Victoria. Read more and discover the 10 programs that aim to shift the dial in key areas of need and opportunity over the next three years.
Victoria’s position as a national leader in health and biomedical research was certainly highlighted in the recent NHMRC Investigator Grants.
With 62 of the 105 Victorian grants awarded going to outstanding researchers within VCCC Alliance member organisations, there is good reason to feel optimistic and proud of the work and innovation happening here and the multi-faceted benefits this offers to the community, our state and the country.
The Australian Brain Cancer Research Alliance (ABCARA) is a new alliance of brain cancer focused researchers and clinician scientists with an interest in adult brain cancer research.
The alliance is seeking to develop a national research collaboration to accelerate developments in brain cancer research and patient outcomes. A first step is to understand the scope of research and use of technology among peers nationwide. A full day symposium will precede the COGNO Annual Scientific Meeting later this month to discuss challenges and opportunities for building a collaborative adult brain cancer network.
Collaborative trial investigates potential for the management of patients with non-small cell lung cancer
An NHMRC-funded investigator-initiated trial has commenced in Victoria with around 100 patients recruited from across VCCC Alliance hospitals. The study is evaluating novel assays to detect circulating tumour DNA (ctDNA) before and after lung cancer surgery.
There are currently no sensitive or specific blood-based biomarkers in clinical use for lung cancer, so the study aims to develop and validate molecular predictive and prognostic markers to improve outcomes for patients with the disease.
The theme for the 2020-21 Annual Report is The Great Reset, reflecting the progression from our Strategic Research Plan 2017-20 to our new Strategic Program Plan, overlaid by our experiences and lessons as research, health and academic institutions during a pandemic.
In FY 20/21, the remaining objectives for the Strategic Research Plan 2017-20 were realised and the final evaluation was submitted to the Victorian Department of Health in October 2020.
Win-win for patients and clinicians as CCI breaks new ground for pulmonary oligometastases treatment
A groundbreaking study emerging from the Centre for Cancer Immunotherapy (CCI) – a joint initiative between the Peter MacCallum Cancer Centre, the University of Melbourne and the VCCC Alliance – has become the latest achievement for the innovative collaboration.
SAFRON II, led by Peter MacCallum Cancer Centre’s Associate Professor Shankar Siva and funded through the VCCC Alliance, addresses a previously unresolved question around the most efficient way to deliver Stereotactic Ablative Radiotherapy (SABR) to patients with low volume metastatic (oligometastatic) pulmonary disease.
Monday Lunch Livestream with Professor Sean Grimmond
Advances in the cancer genome analysis of challenging cancer cases
Over the last decade, genomics has revolutionised our ability to discern the root-cause of malignant cancer and identify its potential therapeutic vulnerabilities, resulting in groundbreaking treatments to fight cancer. Join Professor Sean Grimmond, Director of the University of Melbourne Centre for Cancer Research, for this special presentation that will review how the latest international cancer efforts have provided new foundations for improved cancer-diagnostic tools.
Translating genetic discoveries into primary care practice
Join us to hear from Professor Jon Emery who will deliver the 2021 David Danks Oration.
The Human Genome Project was completed 18 years ago with considerable expectation of benefits to human health and a revolution in healthcare. The research translational pipeline is long but we are now beginning to see how advances in genetic epidemiology and sequencing technology will transform the way GPs practice medicine in the 21st century.
Monday Lunch Livestream: Cervical Cancer Awareness Week
Conquering Cervical Cancer – the role of the Australian Cervical Cancer Foundation
To acknowledge Cervical Cancer Awareness Week, the VCCC Alliance invites you to join Liz Ham, Health Promotion Manager from the Australian Cervical Cancer Foundation (ACCF), Laura Philpott (Program Coordinator, Hedland Well Women’s Centre, WA), and Christine Walters, cervical cancer survivor, for a special presentation on the impact of a cervical cancer diagnosis, and the inequities that exist in ensuring access to preventative measures.
EOI: VCCC Alliance Research & Education Lead, Gynae-Oncology
Join the VCCC's distributed leadership team to enhance relationships across the alliance membership.
The Research & Education Lead for Gynae-Oncology (R&E Lead Gynae-Oncology) will champion the systemisation of collaboration across the VCCC Alliance and members to integrate cancer research, education and clinical care in the continuous improvement of patient outcomes.
Peter Mac is Australia’s only integrated cancer research, treatment and education centre, with multidisciplinary teams that provide care informed by precision in fundamental, translational and clinical research.
The Royal Melbourne Hospital
The Royal Melbourne Hospital (Melbourne Health) provides high-quality cancer treatment programs, translational research, and surgical and medical expertise, as well as other key support services such as clinical care and emergency medicine.
University of Melbourne
Australia’s first ranked research university and medical school, the university provides academic and research expertise to the alliance.
The Royal Women's Hospital
The Women’s provides specialist cancer services for women with breast and gynecological cancer and conducts research into the treatment and care of women with cancer, as well as the specific impacts of gender on cancer.
WEHI is one of Australia’s leading biomedical research organisations, with a strong national and international reputation for performing highly influential basic and translational research.
The Royal Children's Hospital
The Children’s Cancer Centre is the only provider of complex children’s cancer care and stem cell transplantation in Victoria and is a leader in the research and treatment of childhood cancer.
Western Health is the largest provider of treatment for colorectal cancer and a leader in the treatment of upper gastro-intestinal cancers with programs in breast, lung, genitourinary, gynaecology and haematological cancer.
Western Health has on-site radiation therapy and chemotherapy facilities and has a strong palliative care service.
St Vincent's Hospital Melbourne | St Vincent's Institute
A leader in palliative care practice and complex cancer surgery, St Vincent’s Hospital Melbourne also provides oncology and haematology services, on-site radiation therapy and chemotherapy facilities, in addition the hospital houses the Victorian-wide psycho-oncology service.
The hospital shares its campus with St Vincent's Institute, which has fundamental and clinical researchers working on mechanisms of cancer and diseases of cancer survivorship.
Austin Health | Olivia Newton-John Cancer Research Institute
The Olivia Newton-John Cancer Wellness & Research Centre at Austin Health provides world-leading specialist treatment and holistic care including clinical trials both independently and in partnership with the Olivia Newton-John Cancer Research Institute (ONJCRI) – a leader in the development of experimental and breakthrough cancer treatments only metres from where patients are cared for.
Murdoch Children's Research Institute
The MCRI is a leader in understanding the underlying mechanisms and treatment of paediatric cancer and is home to the Children’s Cancer Tissue bank; a world class resource for researchers studying rare solid tumours and leukemia.